• Santosh Anand, Mohammad Azam Ansari, Sambamurthy Kumaraswamy Sukrutha, Mohammad N Alomary, Anmar Anwar Khan, and Abozer Y Elderdery.
• Department of Biotechnology, School of Applied Sciences, REVA University, Bengaluru, Karnataka, India.
• Neuroscience. 2022 Dec 15; 507: 139148139-148.

AbstractInflammation and resolution are highly programmed processes involving a plethora of immune cells. Lipid mediators synthesized from arachidonic acid metabolism play a pivotal role in orchestrating the signaling cascades in the game of inflammation. The majority of the studies carried out so far on inflammation were aimed at inhibiting the generation of inflammatory molecules, whereas recent research has shifted more towards understanding the resolution of inflammation. Owing to chronic inflammation as evident in neuropathophysiology, the resolution of inflammation together with the class of lipid mediators actively involved in its regulation has attracted the attention of the scientific community as therapeutic targets. Both omega-three polyunsaturated fatty acids, eicosapentaenoic acid and docosahexaenoic acid, orchestrate a vital regulatory role in inflammation development. Resolvins derived from these fatty acids comprise the D-and E-series resolvins. A growing body of evidence using in vitro and in vivo models has revealed the pro-resolving and anti-inflammatory potential of resolvins. This systematic review sheds light on the synthesis, specialized receptors, and resolution of inflammation mediated by resolvins in Alzheimer's and Parkinson's disease.Copyright © 2022 IBRO. Published by Elsevier Ltd. All rights reserved.

17 keywords...

hide…